Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3091 | 1868 | 40.1 | 80% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
103 | 71673 | DOPAMINE//PSYCHOPHARMACOLOGY//NUCLEUS ACCUMBENS |
Classes in level below (level 1) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
3623 | 1868 | SIGMA RECEPTOR//SIGMA1 RECEPTOR//SIGMA RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SIGMA RECEPTOR | Author keyword | 297 | 73% | 12% | 227 |
2 | SIGMA1 RECEPTOR | Author keyword | 285 | 81% | 9% | 174 |
3 | SIGMA RECEPTORS | Author keyword | 235 | 75% | 9% | 168 |
4 | SA4503 | Author keyword | 90 | 96% | 1% | 27 |
5 | SIGMA LIGANDS | Author keyword | 58 | 86% | 2% | 30 |
6 | SIGMA BINDING SITES | Author keyword | 57 | 95% | 1% | 19 |
7 | PRE 084 | Author keyword | 52 | 100% | 1% | 18 |
8 | SIGMA 1 RECEPTORS | Author keyword | 47 | 86% | 1% | 24 |
9 | BEHAV NEUROPHARMACOL GRP | Address | 45 | 94% | 1% | 16 |
10 | PENTAZOCINE | Author keyword | 39 | 42% | 4% | 72 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIGMA RECEPTOR | 297 | 73% | 12% | 227 | Search SIGMA+RECEPTOR | Search SIGMA+RECEPTOR |
2 | SIGMA1 RECEPTOR | 285 | 81% | 9% | 174 | Search SIGMA1+RECEPTOR | Search SIGMA1+RECEPTOR |
3 | SIGMA RECEPTORS | 235 | 75% | 9% | 168 | Search SIGMA+RECEPTORS | Search SIGMA+RECEPTORS |
4 | SA4503 | 90 | 96% | 1% | 27 | Search SA4503 | Search SA4503 |
5 | SIGMA LIGANDS | 58 | 86% | 2% | 30 | Search SIGMA+LIGANDS | Search SIGMA+LIGANDS |
6 | SIGMA BINDING SITES | 57 | 95% | 1% | 19 | Search SIGMA+BINDING+SITES | Search SIGMA+BINDING+SITES |
7 | PRE 084 | 52 | 100% | 1% | 18 | Search PRE+084 | Search PRE+084 |
8 | SIGMA 1 RECEPTORS | 47 | 86% | 1% | 24 | Search SIGMA+1+RECEPTORS | Search SIGMA+1+RECEPTORS |
9 | PENTAZOCINE | 39 | 42% | 4% | 72 | Search PENTAZOCINE | Search PENTAZOCINE |
10 | SIGMA1 RECEPTORS | 38 | 93% | 1% | 14 | Search SIGMA1+RECEPTORS | Search SIGMA1+RECEPTORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | H 3 PENTAZOCINE | 159 | 94% | 3% | 58 |
2 | SA4503 | 111 | 100% | 2% | 32 |
3 | GUINEA PIG BRAIN | 102 | 27% | 17% | 324 |
4 | EXTRACELLULAR ACETYLCHOLINE LEVEL | 86 | 96% | 1% | 26 |
5 | INDUCED NEURONAL ACTIVATION | 77 | 71% | 3% | 62 |
6 | SIGMA1 RECEPTOR | 57 | 59% | 3% | 65 |
7 | POTENTIAL ANTIPSYCHOTIC DRUG | 47 | 88% | 1% | 22 |
8 | INDUCED SPINAL SENSITIZATION | 41 | 90% | 1% | 18 |
9 | SIGMA1 BINDING SITE | 37 | 100% | 1% | 14 |
10 | DECREASES BRAIN INJURY | 35 | 89% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The pharmacology of sigma-1 receptors | 2009 | 236 | 162 | 89% |
The sigma-1 receptor chaperone as an inter-organelle signaling modulator | 2010 | 107 | 101 | 91% |
Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands | 2008 | 142 | 211 | 81% |
Recent Advances in the Development of Sigma-1 Receptor Ligands | 2015 | 1 | 87 | 91% |
The sigma-1 receptor: roles in neuronal plasticity and disease | 2012 | 40 | 92 | 70% |
Sigma receptors: biology and therapeutic potential | 2004 | 149 | 187 | 92% |
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders | 2011 | 58 | 131 | 60% |
sigma-1 receptor ligands - Potential in the treatment of neuropsychiatric disorders | 2004 | 160 | 119 | 71% |
Sigma Receptors in Oncology: Therapeutic and Diagnostic Applications of Sigma Ligands | 2010 | 39 | 173 | 92% |
SIGMA-RECEPTORS - BIOLOGY AND FUNCTION | 1990 | 722 | 159 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BEHAV NEUROPHARMACOL GRP | 45 | 94% | 0.9% | 16 |
2 | PHARMAZEUT MED CHEM | 20 | 25% | 3.7% | 69 |
3 | UNIT RECEPTOR BIOCHEM PHARMACOL | 18 | 83% | 0.5% | 10 |
4 | CELLULAR PATHOBIOL SECT | 16 | 60% | 1.0% | 18 |
5 | CELLULAR PATHOBIOL UNIT | 13 | 61% | 0.7% | 14 |
6 | DRUG DISCOVERY PRECLIN DEV | 12 | 54% | 0.8% | 15 |
7 | PHARMAZEUT MED CHEM WESTFAL | 9 | 83% | 0.3% | 5 |
8 | MU REACTOR | 9 | 67% | 0.4% | 8 |
9 | BRAIN PHYSIOL UNIT | 6 | 80% | 0.2% | 4 |
10 | CELLULAR ST S SIGNALING UNIT | 5 | 63% | 0.3% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000027449 | PREPULSE INHIBITION//D SERINE//D AMINO ACID OXIDASE |
2 | 0.0000012163 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
3 | 0.0000009708 | METHAMPHETAMINE//CEREBROLYSIN//SURG SCI ANESTHESIOL INTENS CARE MED |
4 | 0.0000008860 | NEUROTROPIN//TELE STEREO EEG//SART STRESS |
5 | 0.0000008618 | IBOGAINE//UNCARIA TOMENTOSA//YOKUKANSAN |
6 | 0.0000008604 | DIMEBON//DIMEBOLIN//REMOXIPRIDE |
7 | 0.0000008482 | C 11RACLOPRIDE//FLUORINE 18//C 11FLB 457 |
8 | 0.0000007004 | NUCLEUS ACCUMBENS//COCAINE//DOPAMINE |
9 | 0.0000006946 | HYPERALGESIA//NEUROPATHIC PAIN//ANTINOCICEPTION |
10 | 0.0000006929 | 1 AZABICYCLO330OCTANE//AZODERIVATIVES//LIDOCAINE ANALOGS |